A
0.019
0.00 (0.00%)
| Previous Close | 0.019 |
| Open | 0.019 |
| Volume | 60,000 |
| Avg. Volume (3M) | 204,407 |
| Market Cap | 12,144,837 |
| Price / Sales | 2.95 |
| Price / Book | 1.20 |
| 52 Weeks Range | |
| Earnings Date | 24 Feb 2025 - 28 Feb 2025 |
| Profit Margin | -167.57% |
| Operating Margin (TTM) | -148.02% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | 82.60% |
| Total Debt/Equity (MRQ) | 0.84% |
| Current Ratio (MRQ) | 6.39 |
| Operating Cash Flow (TTM) | -4.69 M |
| Levered Free Cash Flow (TTM) | -2.65 M |
| Return on Assets (TTM) | -29.88% |
| Return on Equity (TTM) | -55.06% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | ATOMO DIAG FPO [AT1] | - | - |
AIStockmoo Score
0.8
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.0 |
| Average | 0.75 |
|
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 42.00% |
| % Held by Institutions | 10.14% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |